Julia Aijun Wang

Insider Reports History

Location
Grand Cayman, Cayman Islands
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Julia Aijun Wang
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Julia Aijun Wang:

Company Role Class Num Shares Value Price $ Report Date Ownership
BeiGene, Ltd. Chief Financial Officer Ordinary Shares 426,595 $88,611,076 $207.72 01 Jul 2024 Direct
LABCORP HOLDINGS INC. Chief Financial Officer, EVP Restricted Stock Unit 4,367 $1,075,461 $246.27 11 Feb 2025 Direct
LABCORP HOLDINGS INC. Chief Financial Officer, EVP Common Stock 557 $137,991 $247.74 06 Feb 2025 Direct
BeiGene, Ltd. Chief Financial Officer American Depositary Shares 0 $0 $143.90 01 Jul 2024 Direct
BeiGene, Ltd. Chief Financial Officer Share Option (Right to Buy) 256,659 05 Jun 2024 Direct
LABCORP HOLDINGS INC. Chief Financial Officer, EVP Non-qualified Stock Options 7,800 11 Feb 2025 Direct

Insider Reports Filed by Julia Aijun Wang

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LH LABCORP HOLDINGS INC. 11 Feb 2025 2 $0 4 Chief Financial Officer, EVP 13 Feb 2025, 11:18
LH LABCORP HOLDINGS INC. 06 Feb 2025 3 -$83,241 4 Chief Financial Officer, EVP 10 Feb 2025, 09:00
LH LABCORP HOLDINGS INC. 02 Dec 2024 2 $0 4 Chief Financial Officer, EVP 04 Dec 2024, 10:05
LH LABCORP HOLDINGS INC. 02 Dec 2024 0 $0 3 Chief Financial Officer, EVP 03 Dec 2024, 09:11
BGNE BeiGene, Ltd. 01 Jul 2024 1 -$67,919 4 Chief Financial Officer 03 Jul 2024, 17:05
BGNE BeiGene, Ltd. 24 Jun 2024 1 -$139,938 4 Chief Financial Officer 26 Jun 2024, 17:26
BGNE BeiGene, Ltd. 17 Jun 2024 4 -$145,678 4 Chief Financial Officer 20 Jun 2024, 17:26
BGNE BeiGene, Ltd. 05 Jun 2024 2 $0 4 Chief Financial Officer 07 Jun 2024, 16:54
BGNE BeiGene, Ltd. 29 Feb 2024 1 -$66,331 4 Chief Financial Officer 04 Mar 2024, 17:22
BGNE BeiGene, Ltd. 03 Jul 2023 1 -$84,747 4 Chief Financial Officer 06 Jul 2023, 17:02
BGNE BeiGene, Ltd. 23 Jun 2023 1 -$153,594 4 Chief Financial Officer 27 Jun 2023, 17:22
BGNE BeiGene, Ltd. 15 Jun 2023 3 -$36,583 4 Chief Financial Officer 20 Jun 2023, 18:51
BGNE BeiGene, Ltd. 01 Mar 2023 1 -$82,392 4 Chief Financial Officer 03 Mar 2023, 16:00
BGNE BeiGene, Ltd. 01 Jul 2022 1 -$50,244 4/A Chief Financial Officer 18 Jul 2022, 17:22
BGNE BeiGene, Ltd. 22 Jun 2022 2 $0 4 Chief Financial Officer 24 Jun 2022, 17:40
BGNE BeiGene, Ltd. 17 Jun 2022 1 -$21,999 4 Chief Financial Officer 21 Jun 2022, 17:09
BGNE BeiGene, Ltd. 28 Feb 2022 1 $0 4 Chief Financial Officer 02 Mar 2022, 16:12
BGNE BeiGene, Ltd. 01 Jul 2021 1 -$107,512 4 Chief Financial Officer 01 Jul 2021, 16:58
BGNE BeiGene, Ltd. 30 Jun 2021 0 $0 3 Chief Financial Officer 01 Jul 2021, 16:55